Skip to main content
. 2015 Jul 29;13:170. doi: 10.1186/s12916-015-0408-2

Table 2.

Fitted vaccine RTS,S properties

Cohorts Initial efficacy Half-life (exponential decay)
6-12 week 62.7 % 1.12 years
cohort (with 95 % CI 39.5-80.3 %) (with 95 % CI 1-1.43 years)
5-17 month 79.2 % 1.12 years
cohort (with 95 % CI 67.3-84.8 %) (with 95 % CI 1-1.43 years)